Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · RELIGARE

RELIGARE ENT

Financial ServicesFinance₹8171 cr market cap
₹230.30 ▲ +4.19% today As of 19 Nov 2026
52-week low ₹201.1152-week high ₹278.36

-20.6% from the 52-week high · +9.9% above the low

Religare Enterprises Ltd. is a holding company, which engages in the provision of financial services. The company is headquartered in Noida, Uttar Pradesh and currently employs 34 full-time employees. The company went IPO on 2007-11-21. The firm provides diversified financial services. The firm through its subsidiaries, is primarily engaged in the business of broking in securities and commodities, lending and investments, financial advisory services, distribution of third-party financial products, custodial and depository operations, and health insurance services to its clients. Its segments include investment and financing activities, support services, broking related activities, e-governance, and insurance. Its subsidiaries include Religare Capital Markets International (Mauritius) Limited, Religare Capital Markets (Europe) Limited (RCME), Religare Capital Markets (UK) Limited, Religare Capital Markets Corporate Finance Pte. Ltd., Religare Capital Markets Inc, Tobler UK Limited, Religare Capital Markets (HK) Limited, Religare Capital Markets (Singapore) Pte Limited, and Kyte Management Limited, among others.

The short version. RELIGARE ENT reported revenue of ₹2,381 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹-50 crore (down 228.2% year on year). Return on equity was 3.0% in Mar 2026. Promoter holding was 31.26% in Sep 2026, up 31.26 points over 8 quarters.

1 · The price

How has the stock traded?

RELIGARE ENT trades 20.6% below its 52-week high and 9.9% above its 52-week low.

Change over period: —

1M+2.1%
3M-4.2%
6M-3.3%
1Y-15.8%

2 · The business

Is it growing?

Sales, year on year+15.4%

Sep 2026 revenue of ₹2,381 cr.

Profit, year on year-228.2%

Sep 2026 net profit of ₹-50 cr.

Net margin-2.1%

4.0 pts lower than a year earlier.

3-year growth-69.7% profit

Revenue compounded at 20.4% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue23812353246720562064186120281664
Net profit-50-2682-45391099-43
Net margin %-2.1-1.13.3-2.21.90.64.9-2.6
EPS (₹)-1.45-0.772.47-1.361.170.313.0-1.3

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue84597354623546763224248723552346
Net profit861252333082-1539-508-932-1287
Net margin %1.01.73.765.9-47.7-20.4-39.6-54.9
EPS (₹)2.583.797.0695.24-48.26-19.6-36.12-59.33

3 · The quality

How well does it turn capital into profit?

Return on equity was 3.0% in Mar 2026; debt to equity is 0.14.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %3.05.09.9149.8
Return on capital %1.02.96.352.2
EBITDA margin %2.04.69.781.1
Net margin %1.01.73.763.4

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR20.4%27.4%
Profit CAGR-69.7%—
Debt to equity0.14
Interest cover3.4x
Current ratio0.84

4 · The owners

Who holds it, and are they adding?

Promoter holding31.26%

Up 31.26 pts over 8 quarters.

Foreign institutions9.76%

Up 1.72 pts over 8 quarters.

Domestic institutions7.52%

Down 5.62 pts over 8 quarters.

Mutual fund schemes12

+1 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter025.6725.8325.8326.2730.2730.5631.26+31.26
FII8.048.258.17.87.617.859.649.76+1.72
DII13.1411.7611.6210.279.328.529.337.52-5.62
Public78.8254.3254.4556.156.7953.3650.4851.46-27.36

Mutual fund holdings · Oct 2026

12 schemes hold this stock

11 the month before.

  • SAMCO DYNAMIC ASSET ALLOCATION FUND8.48% of NAV
  • SAMCO SPECIAL OPPORTUNITIES FUND6.37% of NAV
  • SAMCO ACTIVE MOMENTUM FUND4.22% of NAV
  • Motilal Oswal Nifty Microcap 250 Index Fund0.61% of NAV
  • Angel One Nifty Total Market Index Fund0.02% of NAV
  • Groww Nifty Total Market Index Fund0.02% of NAV
  • Angel One Nifty Total Market ETF0.02% of NAV
  • Mirae Asset Nifty Total Market Index Fund0.02% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for RELIGARE ENT are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about RELIGARE ENT

What is the RELIGARE ENT share price?

RELIGARE ENT (RELIGARE) last closed at ₹230.30, up 4.19% on the day. Its 52-week range is ₹201.11 to ₹278.36.

What is the market cap of RELIGARE ENT?

RELIGARE ENT has a market capitalisation of about ₹8,171 crore.

How are RELIGARE ENT's latest results?

RELIGARE ENT reported revenue of ₹2,381 crore for Sep 2026, up 15.4% from a year earlier. Net profit was ₹-50 crore (down 228.2% year on year). Return on equity was 3.0% in Mar 2026. Promoter holding was 31.26% in Sep 2026, up 31.26 points over 8 quarters.

Who owns RELIGARE ENT?

As of Sep 2026, shareholding was: Promoter 31.26%, FII 9.76%, DII 7.52%, Public 51.46%.

How many mutual funds hold RELIGARE ENT?

12 mutual fund schemes held RELIGARE ENT in October 2026. That compares with 11 the month before.

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.